Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of the antiplatelet effect of aspirin.

Current pharmaceutical design - 1 Jan 2012

Würtz Morten, Kristensen Steen Dalby, Hvas Anne-Mette, Grove Erik Lerkevang

Abstract excerpt

The concept of "pharmacogenetics" addresses genetically determined variation in how individuals respond to drugs. Accordingly, specific genetic variants have been suggested as contributors to a reduced response to various antiplatelet drugs. Aspirin is a cornerstone in secondary cardiovascular prevention and has been thoroughly investigated. The efficacy of aspirin is well documented, although with considerable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspirin
Share to Cyclooxygenase Inhibitors
Share to Hemorrhage

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Platelet Aggregation Inhibitors

Share to Platelet Function Tests

Share to Platelet Membrane Glycoproteins

Share to Prostaglandin-Endoperoxide Synthases

Share to Purinergic P2Y Receptor Antagonists

Source

Identifiers

PMID: 22724416
DOI: 10.2174/138161212803251907

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of the antiplatelet effect of aspirin.PMID 22724416Read ↗

Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms.Semantic proximity Read ↗

Pharmacogenetics of antiplatelet therapy.Semantic proximity Read ↗

Epoxidase inhibitor-aspirin resistance and the relationship with genetic polymorphisms: a reviewSemantic proximity Read ↗

Pharmacogenetics of Antiplatelet Therapy.Semantic proximity Read ↗

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.Semantic proximity Read ↗

Frequency of Genetic Polymorphisms of COX1 , GPIIIa and P2Y1 in a Chinese Population and Association with Attenuated Response to AspirinSemantic proximity Read ↗

The Impact of Single Nucleotide Polymorphisms and Other Mechanisms on Aspirin Resistance.Semantic proximity Read ↗

Pharmacogenetics of aspirin resistance: a comprehensive systematic review.Semantic proximity Read ↗

Role of platelet glycoprotein polymorphisms in cardiovascular diseases.Semantic proximity Read ↗

The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.Semantic proximity Read ↗

Genetic determinants of response to aspirin: appraisal of 4 candidate genes.Semantic proximity Read ↗

The pharmacogenetics of antiplatelet agents: towards personalized therapy?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.